After Valeant, Short-Seller Citron Is Going After This Pharma Benefits Firm — Fortune

Short seller Citron Research’s Andrew Left has turned his sights on Express Scripts Holding Co, calling the pharmacy benefit manager (PBM) the “culprit behind pharmaceutical price gouging.” Shares of Express Scripts esrx , the largest PBM in the United States, fell 6.7% to close at $70.75 on Nasdaq. Citron, which profits from bets that stock…

via After Valeant, Short-Seller Citron Is Going After This Pharma Benefits Firm — Fortune

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s